Accelerate Brain Cancer Cure, Inc (ABC2) will soon be soliciting proposals for translational research for its 2005 funding cycle. Established in May 2001 by Dan and Steve Case and their families, ABC2 is pursuing its single mission: to accelerate a cure for brain cancer. The mission has been carried forward by the Case families and a visionary board composed of technology and financial leaders. To date, ABC2 has funded 41 proposals from 15 institutions. We encourage investigators to make use of our resources and participate in our urgent mission.

Targeting the acceleration of progress, in what has been an underserved field of research, ABC2 has developed a unique system designed to provide innovative researchers with the venture support they require to make critical translational breakthroughs. We will work actively and partner with investigators to overcome obstacles in achieving the goal of the research.

Content copyright © Accelerate Brain Cancer Cure, Inc.